Related Experiment Video
Updated: Dec 5, 2025

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis
Published on: October 25, 2024
Current concepts in atherosclerosis
Mohammad Alkhalil1,2, Robin P Choudhury1
1Acute Vascular Imaging Centre, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU UK.
Insights
Atherosclerosis involves lipoprotein retention and inflammation, with perivascular adipose tissue emerging as a key factor. Novel therapies targeting lipids and inflammation show promise in reducing cardiovascular events.
Area of Science:
- Cardiovascular Science
- Immunology
- Metabolic Disease
Background:
- Atherosclerosis is a complex disease driven by lipoprotein retention and inflammatory cells.
- Low-density lipoprotein cholesterol (LDL-c) is a known cause, with monocytes and foam cells linked to disease progression.
- Perivascular adipose tissue (PVAT) is increasingly recognized for its role in plaque inflammation.
Purpose of the Study:
- To review the pathogenesis of atherosclerosis, incorporating novel insights.
- To discuss current and emerging therapeutic strategies for atherosclerosis management.
- To highlight the interplay between lipids, inflammation, and PVAT in atherosclerosis.
Main Methods:
- Literature review of atherosclerosis pathogenesis.
- Analysis of emerging data on PVAT and inflammation.
- Evaluation of novel anti-atherosclerotic therapies.
Main Results:
- Lipoprotein retention and inflammation are central to atherosclerosis.
- PVAT influences atherosclerotic plaque inflammatory status.
- Novel therapies like PCSK-9 inhibitors and IL-1ß antibodies demonstrate efficacy.
Conclusions:
- Understanding atherosclerosis requires integrating lipid, inflammatory, and novel factors like PVAT.
- Targeting both lipid retention and inflammation is crucial for effective treatment.
- Emerging therapies offer new hope for managing cardiovascular events in atherosclerosis patients.
Abstract:
Atherosclerosis is a complex disease process. It is increasingly recognised that both lipoprotein retention and inflammatory cellular components are intricately related in the initiation and development of atherosclerotic plaque. LDL-c (cholesterol) has been long established as a cause for atherosclerosis; additionally, inflammatory cells such as monocytes and subsequently foam cells have also been directly linked to the progression of atherosclerotic disease. Emerging data suggest that structures outside vascular intima and media are also closely related to atherosclerosis. Perivascular adipose tissue (PVAT) may be a determinant of the inflammatory status of the atherosclerotic plaque. All these features are becoming extremely relevant as therapies against atherosclerosis are targeting both lipid retention and inflammation. Recently, there has been some success in these novel therapies, such as the proprotein convertase subtilisin-kexin type 9 (PCSK-9) inhibitor evolocumab and the interleukin-1ß neutralising antibody, canakinumab, in reducing cardiovascular events when added to standard therapy such as statin. This review will discuss the pathogenesis of atherosclerosis, including some novel features, and its management using new anti-atherosclerotic drugs.
Related Concept Videos
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Atherosclerosis IV: Nursing Management

